Search for promising antiparkinsonian agents among monoterpene-bearing azaadamantanes

Read full text Summarise with VIRAT
Authors: M.P. Pitukhin, Irina V. Sorokina, С. В. Айдагулова, Konstantin Yu. Ponomarev, K. N. Sorokina, Т. Г. Толстикова, Е. В. Суслов, Konstantin Petrovich Volcho
Cited by: 0
References: 16

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Parkinson’s disease (PD) involves degeneration of nigrostriatal dopaminergic neurons with a consequent imbalance across multiple neurotransmitter systems regulating basal ganglia function. Amantadine (AMD; 1-aminoadamantane) is a low-affinity, uncompetitive NMDA receptor antagonist and a modulator of CNS neurotransmission that alleviates motor symptoms of PD but is limited by modest efficacy. Azaadamantanes bearing a monoterpene moiety are proposed as aminoadamantane analogs with potential to stimulate dopaminergic transmission and antagonize glutamatergic NMDA receptors. Aim of the study was to compare the effects of monoterpene-containing azaadamantanes (K-372, K-818) and AMD on key neurotransmitter systems implicated in PD pathogenesis using validated in vivo models. Material and methods . Male CD-1 and C57BL/6 mice received a single intraperitoneal dose of each agent at 20 mg/kg. Outcomes were measured in the following models: parkinsonism, induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), haloperidol-induced catalepsy, arecoline-induced tremor, yohimbine toxicity, and corazole-induced seizures models. Results and discussion . In the MPTP model, K-372 and K-818 significantly improved locomotor and exploratory activity, indicating dopaminergic stimulation, whereas AMD significantly improved only one locomotor endpoint (p

Fields of Study & Subjects

Parkinson's Disease Mechanisms and Treatments Neurotransmitter Receptor Influence on Behavior Deep Brain Stimulation and Movement Disorders

Publication details

Journal / source
Сибирский научный медицинский журнал
Volume
46
Issue
1
Pages
119–127
Publication date
19 March 2026
Language
EN